{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:45:43Z","timestamp":1788385543199,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117219","type":"journal-article","created":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T21:49:55Z","timestamp":1754862595000},"page":"117219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"P2","title":["Lysosomal TPC2 channel as a new target of chlorpromazine and clomipramine to induce protective autophagy in L-BMAA-induced neurodegeneration"],"prefix":"10.1016","volume":"242","author":[{"given":"Valentina","family":"Tedeschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Ciancio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Magliocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Piccirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Preziuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Spadoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi Di","family":"Muraglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pannaccione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnese","family":"Secondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117219_b0005","doi-asserted-by":"crossref","first-page":"13380","DOI":"10.1073\/pnas.2235808100","article-title":"Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam","volume":"100","author":"Cox","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117219_b0010","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1600-0404.2008.01150.x","article-title":"Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease","volume":"120","author":"Pablo","year":"2009","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bcp.2025.117219_b0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The Drug Repurposing Hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2025.117219_b0020","series-title":"Drug Repurposing - Hypothesis","author":"Badria","year":"2020"},{"key":"10.1016\/j.bcp.2025.117219_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.58647\/DRUGREPO.24.1.0003","article-title":"Drug Repurposing: then, now, and in the Future","volume":"1","author":"Mucke","year":"2024","journal-title":"Drug Repurposing"},{"key":"10.1016\/j.bcp.2025.117219_b0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1134\/S1068162023020139","article-title":"Drug Repurposing: an Effective Tool in Modern Drug Discovery","volume":"49","author":"Kulkarni","year":"2023","journal-title":"Russ. J. Bioorg. Chem."},{"key":"10.1016\/j.bcp.2025.117219_b0035","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020078118","article-title":"Antipsychotic drugs counteract autophagy and mitophagy in multiple sclerosis","volume":"118","author":"Patergnani","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2025.117219_b0040","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.schres.2010.02.1068","article-title":"Haloperidol activates quiescent oligodendroglia precursor cells in the adult mouse brain","volume":"119","author":"Wang","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.bcp.2025.117219_b0045","article-title":"Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis","volume":"3","author":"Green","year":"2017","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"10.1016\/j.bcp.2025.117219_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104430","article-title":"Treatment with the antipsychotic agent, risperidone, reduces disease severity in experimental autoimmune encephalomyelitis","volume":"9","author":"O'Sullivan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2025.117219_b0055","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/sj.mp.4002064","article-title":"Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes","volume":"13","author":"Xiao","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bcp.2025.117219_b0060","article-title":"Lysosomal Channels as New Molecular Targets in the Pharmacological Therapy of Neurodegenerative Diseases via Autophagy Regulation","author":"Tedeschi","year":"2024","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bcp.2025.117219_b0065","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201003122","article-title":"\u03b1-Synuclein impairs macroautophagy: implications for Parkinson's disease","volume":"190","author":"Winslow","year":"2010","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117219_b0070","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.cell.2010.05.008","article-title":"Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations","volume":"141","author":"Lee","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117219_b0075","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcp.2025.117219_b0080","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.1038\/s41598-019-46708-5","article-title":"The activation of Mucolipin TRP channel 1 (TRPML1) protects motor neurons from L-BMAA neurotoxicity by promoting autophagic clearance","volume":"9","author":"Tedeschi","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.117219_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107491","article-title":"Nanoparticles encapsulating phosphatidylinositol derivatives promote neuroprotection and functional improvement in preclinical models of ALS via a long-lasting activation of TRPML1 lysosomal channel","volume":"210","author":"Tedeschi","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117219_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106020","article-title":"Pharmacological inhibition of lysosomal two-pore channel 2 (TPC2) confers neuroprotection in stroke via autophagy regulation","volume":"178","author":"Tedeschi","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2025.117219_b0095","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ptr.5538","article-title":"Protective Effects of Gastrodin against Autophagy-Mediated Astrocyte Death","volume":"30","author":"Wang","year":"2016","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bcp.2025.117219_b0100","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1523\/JNEUROSCI.1066-19.2019","article-title":"Autophagy in Myelinating Glia","volume":"40","author":"Belgrad","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117219_b0105","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/nrd2272","article-title":"Potential therapeutic applications of autophagy","volume":"6","author":"Rubinsztein","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bcp.2025.117219_b0110","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/ncb3114","article-title":"Lysosomal calcium signalling regulates autophagy through calcineurin and \u200bTFEB","volume":"17","author":"Medina","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bcp.2025.117219_b0115","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.C110.216580","article-title":"Nicotinic acid adenine dinucleotide phosphate (NAADP) regulates autophagy in cultured astrocytes","volume":"286","author":"Pereira","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117219_b0120","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ceca.2014.09.010","article-title":"A primer of NAADP-mediated Ca(2+) signalling: from sea urchin eggs to mammalian cells","volume":"58","author":"Galione","year":"2015","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bcp.2025.117219_b0125","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51423","article-title":"Agonist-specific voltage-dependent gating of lysosomal two-pore Na+ channels","volume":"8","author":"Zhang","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2025.117219_b0130","doi-asserted-by":"crossref","first-page":"21219","DOI":"10.1074\/jbc.C110.143123","article-title":"Characterization of two-pore channel 2 (TPCN2)-mediated Ca2+ currents in isolated lysosomes","volume":"285","author":"Schieder","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117219_b0135","doi-asserted-by":"crossref","unstructured":"Gerndt S., Chen C.C., Chao Y.K., Yuan Y., Burgstaller S., Scotto Rosato A., Krogsaeter E., Urban N., Jacob K., Nguyen O.N.P., Miller M.T., Keller M., Vollmar A.M., Gudermann T., Zierler S., Schredelseker J., Schaefer M., Biel M., Malli R., Wahl-Schott C., Bracher F., Patel S., Grimm C. Agonist-mediated switching of ion selectivity in TPC2 differentially promotes lysosomal function. Elife, 2020; 9:e54712. doi: 10.7554\/eLife.54712.","DOI":"10.7554\/eLife.54712"},{"key":"10.1016\/j.bcp.2025.117219_b0140","article-title":"TPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann-pick type C1, and Batten disease","volume":"14","author":"Scotto","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bcp.2025.117219_b0145","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1080\/15548627.2021.1954779","article-title":"LRRK2 is required for CD38-mediated NAADP-Ca2+ signaling and the downstream activation of TFEB (transcription factor EB) in immune cells","volume":"18","author":"Nabar","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.bcp.2025.117219_b0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/aja.1001940306","article-title":"Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons","volume":"194","author":"Cashman","year":"1992","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.bcp.2025.117219_b0155","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/cdd.2016.154","article-title":"ApoSOD1 lacking dismutase activity neuroprotects motor neurons exposed to beta-methylamino-L-alanine through the Ca2+\/Akt\/ERK1\/2 prosurvival pathway","volume":"24","author":"Petrozziello","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bcp.2025.117219_b0160","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cell.2012.08.036","article-title":"TPC proteins are phosphoinositide- activated sodium-selective ion channels in endosomes and lysosomes","volume":"151","author":"Wang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2025.117219_b0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ncomms1037","article-title":"PI(3,5)P(2) controls membrane trafficking by direct activation of mucolipin Ca(2+) release channels in the endolysosome","volume":"1","author":"Dong","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117219_b0170","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/bs.mcb.2014.10.022","article-title":"Lysosome electrophysiology","volume":"126","author":"Zhong","year":"2015","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.bcp.2025.117219_b0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000252","article-title":"Rapamycin directly activates lysosomal mucolipin TRP channels independent of mTOR","volume":"17","author":"Zhang","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bcp.2025.117219_b0180","doi-asserted-by":"crossref","first-page":"6740","DOI":"10.1523\/JNEUROSCI.23-17-06740.2003","article-title":"Beta-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex","volume":"23","author":"Dougherty","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2025.117219_b0185","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ceca.2007.01.006","article-title":"BHK cells transfected with NCX3 are more resistant to hypoxia followed by reoxygenation than those transfected with NCX1 and NCX2: possible relationship with mitochondrial membrane potential","volume":"42","author":"Secondo","year":"2007","journal-title":"Cell Calcium"},{"key":"10.1016\/j.bcp.2025.117219_b0190","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/antiox13080999","article-title":"Involvement of KV3.4 Channel in Parkinson's Disease: a Key Player in the Control of Midbrain and Striatum Differential Vulnerability during Disease Progression?","volume":"13","author":"Magliocca","year":"2024","journal-title":"Antioxidants (basel)"},{"key":"10.1016\/j.bcp.2025.117219_b0195","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s42255-020-0173-1","article-title":"T1D progression is associated with loss of CD3+CD56+ regulatory T cells that control CD8+ T cell effector functions","volume":"2","author":"Terrazzano","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/j.bcp.2025.117219_b0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fcell.2019.00397","article-title":"Blockage of Autophagic Flux and Induction of Mitochondria Fragmentation by Paroxetine Hydrochloride in Lung Cancer Cells Promotes Apoptosis via the ROS-MAPK Pathway","volume":"7","author":"Wang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2025.117219_b0205","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.expneurol.2006.04.017","article-title":"BMAA selectively injures motor neurons via AMPA\/kainate receptor activation","volume":"201","author":"Rao","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bcp.2025.117219_b0210","doi-asserted-by":"crossref","unstructured":"Beri J., Nash T., Martin R.M., Bereman M.S. Exposure to BMAA mirrors molecular processes linked to neurodegenerative disease. Proteomics, 2017; 17:10.1002\/pmic.201700161. doi: 10.1002\/pmic.201700161.","DOI":"10.1002\/pmic.201700161"},{"key":"10.1016\/j.bcp.2025.117219_b0215","doi-asserted-by":"crossref","unstructured":"Gilley J., Jackson O., Pipis M., Estiar M.A., Al-Chalabi A., Danzi M.C., van Eijk K.R., Goutman S.A., Harms M.B., Houlden H., Iacoangeli A., Kaye J., Lima L.; Queen Square Genomics; Ravits J., Rouleau G.A., Sch\u00fcle R., Xu J., Z\u00fcchner S., Cooper-Knock J., Gan-Or Z., Reilly M.M., Coleman M.P. Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders. Elife, 2021; 10:e70905. doi: 10.7554\/eLife.70905.","DOI":"10.7554\/eLife.70905"},{"key":"10.1016\/j.bcp.2025.117219_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-021-00511-x","article-title":"Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients","volume":"17","author":"Bloom","year":"2022","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bcp.2025.117219_b0225","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1021\/acs.biochem.3c00081","article-title":"SARM1, an Enzyme involved in Axon Degeneration, Catalyzes Multiple Activities through a Ternary complex Mechanism","volume":"62","author":"Icso","year":"2023","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2025.117219_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.103812","article-title":"SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites","volume":"25","author":"Angeletti","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.bcp.2025.117219_b0235","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1007\/s00415-017-8647-0","article-title":"An open-label study to assess the feasibility and tolerability of rilmenidine for the treatment of Huntington's disease","volume":"264","author":"Underwood","year":"2017","journal-title":"J. Neurol."},{"key":"10.1016\/j.bcp.2025.117219_b0240","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.1038\/s41467-023-40734-8","article-title":"Randomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis","volume":"14","author":"Mandrioli","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.117219_b0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/14728214.2024.2333420","article-title":"Evaluating emerging drugs in phase II & III for the treatment of amyotrophic lateral sclerosis","volume":"29","author":"Li","year":"2024","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.bcp.2025.117219_b0250","doi-asserted-by":"crossref","first-page":"8448","DOI":"10.3390\/molecules27238448","article-title":"Emerging potential of the Phosphodiesterase (PDE) Inhibitor Ibudilast for Neurodegenerative Diseases: an Update on Preclinical and Clinical evidence","volume":"27","author":"Angelopoulou","year":"2022","journal-title":"Molecules"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T05:16:18Z","timestamp":1761455778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225004848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"alternative-id":["S0006295225004848"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117219","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysosomal TPC2 channel as a new target of chlorpromazine and clomipramine to induce protective autophagy in L-BMAA-induced neurodegeneration","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117219"}}